Mesoionic compounds: Difference between revisions
Content deleted Content added
m Open access bot: doi updated in citation with #oabot. |
m Open access bot: doi updated in citation with #oabot. |
||
| Line 14: | Line 14: | ||
* {{cite journal |pmid=15199390 |year=2004 |last1=Senff-Ribeiro |first1=A |last2=Echevarria |first2=A |last3=Silva |first3=EF |last4=Franco |first4=CR |last5=Veiga |first5=SS |last6=Oliveira |first6=MB |title=Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma |volume=91 |issue=2 |pages=297–304 |doi=10.1038/sj.bjc.6601946 |pmc=2409799 |journal=British Journal of Cancer}} |
* {{cite journal |pmid=15199390 |year=2004 |last1=Senff-Ribeiro |first1=A |last2=Echevarria |first2=A |last3=Silva |first3=EF |last4=Franco |first4=CR |last5=Veiga |first5=SS |last6=Oliveira |first6=MB |title=Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma |volume=91 |issue=2 |pages=297–304 |doi=10.1038/sj.bjc.6601946 |pmc=2409799 |journal=British Journal of Cancer}} |
||
* {{cite journal |pmid=19483269 |year=2009 |last1=Mickleburgh |first1=I |last2=Geng |first2=F |last3=Tiley |first3=L |title=Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity |volume=19 |issue=5 |pages=213–8 |journal=Antiviral Chemistry & Chemotherapy |doi=10.1177/095632020901900504|doi-access=free }} |
* {{cite journal |pmid=19483269 |year=2009 |last1=Mickleburgh |first1=I |last2=Geng |first2=F |last3=Tiley |first3=L |title=Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity |volume=19 |issue=5 |pages=213–8 |journal=Antiviral Chemistry & Chemotherapy |doi=10.1177/095632020901900504|doi-access=free }} |
||
* {{cite journal |doi=10.1002/cbf.932 |title=Interference of MI-D, a new mesoionic compound, on artificial and native membranes |year=2002 |last1=Cadena |first1=Silvia M.S.C. |last2=Carnieri |first2=Eva G.S. |last3=Echevarria |first3=Aurea |last4=De Oliveira |first4=Maria Benigna Martinelli |journal=Cell Biochemistry and Function |volume=20 |pages=31–7 |pmid=11835268 |issue=1}} |
* {{cite journal |doi=10.1002/cbf.932 |title=Interference of MI-D, a new mesoionic compound, on artificial and native membranes |year=2002 |last1=Cadena |first1=Silvia M.S.C. |last2=Carnieri |first2=Eva G.S. |last3=Echevarria |first3=Aurea |last4=De Oliveira |first4=Maria Benigna Martinelli |journal=Cell Biochemistry and Function |volume=20 |pages=31–7 |pmid=11835268 |issue=1|doi-access=free }} |
||
* {{cite journal |doi=10.1107/S0108270183009348 |title=Structure of the mesoionic compound ''N''-[1-methyl-3-(''p''-tolyl)-4-(1,2,3-triazolio)]acetamidate (MMTAT), C12H14N4O |year=1983 |last1=Papageorgiou |first1=M. |last2=Kokkou |first2=S. C. |last3=Rentzeperis |first3=P. J. |last4=Tsoleridis |first4=C. |journal=Acta Crystallographica Section C |volume=39 |issue=11 |pages=1581–1583}} |
* {{cite journal |doi=10.1107/S0108270183009348 |title=Structure of the mesoionic compound ''N''-[1-methyl-3-(''p''-tolyl)-4-(1,2,3-triazolio)]acetamidate (MMTAT), C12H14N4O |year=1983 |last1=Papageorgiou |first1=M. |last2=Kokkou |first2=S. C. |last3=Rentzeperis |first3=P. J. |last4=Tsoleridis |first4=C. |journal=Acta Crystallographica Section C |volume=39 |issue=11 |pages=1581–1583}} |
||
* {{cite journal |doi=10.1021/jo00821a022 |title=Mesoionic compounds. XIV. Mesoionic compounds of the imidazole series |year=1971 |last1=Potts |first1=K. T. |last2=Husain |first2=Syeda |journal=The Journal of Organic Chemistry |volume=36 |issue=22 |pages=3368–3372}} |
* {{cite journal |doi=10.1021/jo00821a022 |title=Mesoionic compounds. XIV. Mesoionic compounds of the imidazole series |year=1971 |last1=Potts |first1=K. T. |last2=Husain |first2=Syeda |journal=The Journal of Organic Chemistry |volume=36 |issue=22 |pages=3368–3372}} |
||
Latest revision as of 22:28, 10 December 2023
In chemistry, mesoionic compounds are one in which a heterocyclic structure is dipolar and where both the negative and the positive charges are delocalized.[1] A completely uncharged structure cannot be written and mesoionic compounds cannot be represented satisfactorily by any one mesomeric structure.[1] Mesoionic compounds are a subclass of betaines.[1] Examples are sydnones and sydnone imines (e.g. the stimulant mesocarb), münchnones,[1][2] and mesoionic carbenes.
The formal positive charge is associated with the ring atoms and the formal negative charge is associated either with ring atoms or an exocyclic nitrogen or other atom.[3] These compounds are stable zwitterionic compounds[4] and belong to nonbenzenoid aromatics.[5]
See also
[edit]References
[edit]- ^ a b c d IUPAC, Compendium of Chemical Terminology, 2nd ed. (the "Gold Book") (1997). Online corrected version: (2006–) "mesoionic compounds". doi:10.1351/goldbook.M03842
- ^ Ollis, W.David; Stanforth, Stepher P.; Ramsden, Christopher A. (1985). "Heterocyclic mesomeric betaines". Tetrahedron. 41 (12): 2239–2329. doi:10.1016/S0040-4020(01)96625-6.
- ^ "SYDNONES" (PDF).[page needed]
- ^ "Seeking Mesoionic Compounds".
- ^ Badami, Bharati V (2006). "Mesoionic compounds". Resonance. 11 (10): 40–48. doi:10.1007/BF02835674.
Further reading
[edit]- Senff-Ribeiro, A; Echevarria, A; Silva, EF; Franco, CR; Veiga, SS; Oliveira, MB (2004). "Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma". British Journal of Cancer. 91 (2): 297–304. doi:10.1038/sj.bjc.6601946. PMC 2409799. PMID 15199390.
- Mickleburgh, I; Geng, F; Tiley, L (2009). "Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity". Antiviral Chemistry & Chemotherapy. 19 (5): 213–8. doi:10.1177/095632020901900504. PMID 19483269.
- Cadena, Silvia M.S.C.; Carnieri, Eva G.S.; Echevarria, Aurea; De Oliveira, Maria Benigna Martinelli (2002). "Interference of MI-D, a new mesoionic compound, on artificial and native membranes". Cell Biochemistry and Function. 20 (1): 31–7. doi:10.1002/cbf.932. PMID 11835268.
- Papageorgiou, M.; Kokkou, S. C.; Rentzeperis, P. J.; Tsoleridis, C. (1983). "Structure of the mesoionic compound N-[1-methyl-3-(p-tolyl)-4-(1,2,3-triazolio)]acetamidate (MMTAT), C12H14N4O". Acta Crystallographica Section C. 39 (11): 1581–1583. doi:10.1107/S0108270183009348.
- Potts, K. T.; Husain, Syeda (1971). "Mesoionic compounds. XIV. Mesoionic compounds of the imidazole series". The Journal of Organic Chemistry. 36 (22): 3368–3372. doi:10.1021/jo00821a022.